Cerus (CERS) Earnings Date & Reports

Industry: @Medical Specialties

A.I. Advisor

published Earnings

CERS is expected to report earnings to rise 6.67% to -3 cents per share on October 31

Q3'24

Est.

$-0.03

Q2'24

Beat

by $0.01

Q1'24

Est.

$-0.05

Q4'23

Beat

by $0.02

Q3'23

Beat

by $0.01

The last earnings report on August 01 showed earnings per share of -2 cents, beating the estimate of -3 cents. With 840.10K shares outstanding, the current market capitalization sits at 342.62M.

View a ticker or compare two or three

Compare

CERS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CERS
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of the INTERCEPT Blood System for platelets and plasma

Industry MedicalSpecialties

Profile

Fundamentals

Details

Industry

Medical Specialties

Address

1220 Concord Avenue

Phone

+1 925 288-6000

Employees

288

Web

https://www.cerus.com